Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine

被引:88
|
作者
Watanabe, Yasunori [1 ,2 ]
Mendonca, Luiza [3 ]
Allen, Elizabeth R. [4 ]
Howe, Andrew [5 ]
Lee, Mercede [6 ]
Allen, Joel D. [1 ]
Chawla, Himanshi [1 ]
Pulido, David [4 ]
Donnellan, Francesca [4 ]
Davies, Hannah [4 ]
Ulaszewska, Marta [4 ]
Belij-Rammerstorfer, Sandra [4 ,7 ]
Morris, Susan [4 ]
Krebs, Anna-Sophia [3 ]
Dejnirattisai, Wanwisa [6 ]
Mongkolsapaya, Juthathip [8 ,9 ]
Supasa, Piyada [6 ]
Screaton, Gavin R. [6 ,10 ]
Green, Catherine M. [6 ]
Lambe, Teresa [4 ,7 ]
Zhang, Peijun [3 ,5 ]
Gilbert, Sarah C. [4 ,7 ]
Crispin, Max [1 ]
机构
[1] Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England
[2] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England
[3] Univ Oxford, Nuffield Dept Med, Div Struct Biol, Oxford OX3 7BN, England
[4] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England
[5] Diamond Light Source, Electron Bioimaging Ctr, Didcot OX11 0DE, Oxon, England
[6] Univ Oxford, Wellcome Ctr Human Genet, Oxford OX3 7BN, England
[7] NIHR Oxford Biomed Res Ctr, Oxford, England
[8] Univ Oxford, Chinese Acad Med Sci CAMS Oxford Inst COI, Oxford OX3 7BN, England
[9] Mahidol Univ, Siriraj Hosp, Fac Med, Dengue Hemorrhag Fever Res Unit,Off Res & Dev, Bangkok, Thailand
[10] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford OX3 7BN, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会; 英国惠康基金;
关键词
CRYO-EM; GLYCOSYLATION; VISUALIZATION; CORONAVIRUS;
D O I
10.1021/acscentsci.1c00080
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Vaccine development against the SARS-CoV-2 virus focuses on the principal target of the neutralizing immune response, the spike (S) glycoprotein. Adenovirus-vectored vaccines offer an effective platform for the delivery of viral antigen, but it is important for the generation of neutralizing antibodies that they produce appropriately processed and assembled viral antigen that mimics that observed on the SARS-CoV-2 virus. Here, we describe the structure, conformation, and glycosylation of the S protein derived from the adenovirus-vectored ChAdOx1 nCoV-19/AZD1222 vaccine. We demonstrate native-like post-translational processing and assembly, and reveal the expression of S proteins on the surface of cells adopting the trimeric prefusion conformation. The data presented here confirm the use of ChAdOx1 adenovirus vectors as a leading platform technology for SARS-CoV-2 vaccines.
引用
收藏
页码:594 / 602
页数:9
相关论文
共 50 条
  • [1] ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
    Marsh, Glenn A.
    McAuley, Alexander J.
    Au, Gough G.
    Riddell, Sarah
    Layton, Daniel
    Singanallur, Nagendrakumar B.
    Layton, Rachel
    Payne, Jean
    Durr, Peter A.
    Bender, Hannah
    Barr, Jennifer A.
    Bingham, John
    Boyd, Victoria
    Brown, Sheree
    Bruce, Matthew P.
    Burkett, Kathie
    Eastwood, Teresa
    Edwards, Sarah
    Gough, Tamara
    Halpin, Kim
    Harper, Jenni
    Holmes, Clare
    Horman, William S. J.
    van Vuren, Petrus Jansen
    Lowther, Suzanne
    Maynard, Kate
    McAuley, Kristen D.
    Neave, Matthew J.
    Poole, Timothy
    Rootes, Christina
    Rowe, Brenton
    Soldani, Elisha
    Stevens, Vittoria
    Stewart, Cameron R.
    Suen, Willy W.
    Tachedjian, Mary
    Todd, Shawn
    Trinidad, Lee
    Walter, Duane
    Watson, Naomi
    Drew, Trevor W.
    Gilbert, Sarah C.
    Lambe, Teresa
    Vasan, S. S.
    [J]. NPJ VACCINES, 2021, 6 (01)
  • [2] ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
    Glenn A. Marsh
    Alexander J. McAuley
    Gough G. Au
    Sarah Riddell
    Daniel Layton
    Nagendrakumar B. Singanallur
    Rachel Layton
    Jean Payne
    Peter A. Durr
    Hannah Bender
    Jennifer A. Barr
    John Bingham
    Victoria Boyd
    Sheree Brown
    Matthew P. Bruce
    Kathie Burkett
    Teresa Eastwood
    Sarah Edwards
    Tamara Gough
    Kim Halpin
    Jenni Harper
    Clare Holmes
    William S. J. Horman
    Petrus Jansen van Vuren
    Suzanne Lowther
    Kate Maynard
    Kristen D. McAuley
    Matthew J. Neave
    Timothy Poole
    Christina Rootes
    Brenton Rowe
    Elisha Soldani
    Vittoria Stevens
    Cameron R. Stewart
    Willy W. Suen
    Mary Tachedjian
    Shawn Todd
    Lee Trinidad
    Duane Walter
    Naomi Watson
    Trevor W. Drew
    Sarah C. Gilbert
    Teresa Lambe
    S. S. Vasan
    [J]. npj Vaccines, 6
  • [3] Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
    Sue Ann Costa Clemens
    Pedro M. Folegatti
    Katherine R. W. Emary
    Lily Yin Weckx
    Jeremy Ratcliff
    Sagida Bibi
    Ana Verena De Almeida Mendes
    Eveline Pipolo Milan
    Ana Pittella
    Alexandre V. Schwarzbold
    Eduardo Sprinz
    Parvinder K. Aley
    David Bonsall
    Christophe Fraser
    Michelle Fuskova
    Sarah C. Gilbert
    Daniel Jenkin
    Sarah Kelly
    Simon Kerridge
    Teresa Lambe
    Natalie G. Marchevsky
    Yama F. Mujadidi
    Emma Plested
    Maheshi N. Ramasamy
    Peter Simmonds
    Tanya Golubchik
    Merryn Voysey
    Andrew J. Pollard
    [J]. Nature Communications, 12
  • [4] AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions
    Ahmad, Md. Altamash
    Kaur, Harleen
    Kumari, Pratima
    Singh, Ravinder
    Kaur, Rupinder
    Chopra, Hitesh
    Sardana, Ojus
    Bin Emran, Talha
    Dhama, Kuldeep
    [J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2023, 17 (01): : 12 - 22
  • [5] Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
    Clemens, Sue Ann Costa
    Folegatti, Pedro M.
    Emary, Katherine R. W.
    Weckx, Lily Yin
    Ratcliff, Jeremy
    Bibi, Sagida
    Mendes, Ana Verena De Almeida
    Milan, Eveline Pipolo
    Pittella, Ana
    Schwarzbold, Alexandre, V
    Sprinz, Eduardo
    Aley, Parvinder K.
    Bonsall, David
    Fraser, Christophe
    Fuskova, Michelle
    Gilbert, Sarah C.
    Jenkin, Daniel
    Kelly, Sarah
    Kerridge, Simon
    Lambe, Teresa
    Marchevsky, Natalie G.
    Mujadidi, Yama F.
    Plested, Emma
    Ramasamy, Maheshi N.
    Simmonds, Peter
    Golubchik, Tanya
    Voysey, Merryn
    Pollard, Andrew J.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)
    Stebbings, Richard
    Jones, Christopher
    Cotton, Peter
    Armour, Gillian
    Maguire, Shaun
    Skellett, Vicky
    Tang, Chi-Man
    Goodman, Joanne
    Brady, Tyler
    Takahashi, Virginia
    Daunt, Andrew
    Lapointe, Jean-Martin
    Cohen, Taylor S.
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
    Lodge, Archie
    [J]. LANCET, 2020, 396 (10261): : 1486 - 1486
  • [8] Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2
    Lee, Sang Won
    Lee, Hyun
    Lee, Sun-Kyung
    Moon, Ji-Yong
    Moon, SeolHwa
    Chung, Sung Jun
    Yeo, Yoomi
    Park, Tai Sun
    Park, Dong Won
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Sang-Heon
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [9] AZ arm: Delayed cutaneous reaction to ChAdOx1 nCoV-19 (AZD1222) vaccine
    Wei-Kai, Hung
    Chi, Ching-Chi
    Wang, Shu-Hui
    [J]. DERMATOLOGICA SINICA, 2022, 40 (01) : 52 - 53
  • [10] Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients
    Bhadauria, Dharmendra S.
    Katiyar, Harshita
    Goel, Amit
    Tiwari, Prachi
    Kishore, Ravi V. Krishna
    Aggarwal, Amita
    Verma, Alka
    Khetan, Dheeraj
    Kaul, Anupma
    Yachha, Monika
    Behera, Manas Ranjan
    Yadav, Brijesh
    Prasad, Narayan
    [J]. VACCINES, 2022, 10 (10)